0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-24.76%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
46.87%
Positive EBIT growth while 0819.HK is negative. John Neff might see a substantial edge in operational management.
46.87%
Positive operating income growth while 0819.HK is negative. John Neff might view this as a competitive edge in operations.
-112.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-112.61%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-114.85%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.05%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-14.84%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-96.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-33.83%
Negative 10Y revenue/share CAGR while 0819.HK stands at 1454.36%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.53%
Negative 5Y CAGR while 0819.HK stands at 191.34%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-33.91%
Negative 3Y CAGR while 0819.HK stands at 119.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2026.74%
Negative 10Y OCF/share CAGR while 0819.HK stands at 7482.36%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-330.94%
Negative 5Y OCF/share CAGR while 0819.HK is at 297.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
-107.08%
Negative 3Y OCF/share CAGR while 0819.HK stands at 5.13%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.98%
Negative 10Y net income/share CAGR while 0819.HK is at 289.48%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.81%
Negative 5Y net income/share CAGR while 0819.HK is 1134.61%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Negative 3Y CAGR while 0819.HK is 51.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
631.56%
10Y equity/share CAGR above 1.5x 0819.HK's 290.41%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
14.54%
Below 50% of 0819.HK's 83.62%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
Below 50% of 0819.HK's 66.16%. Michael Burry suspects a serious short-term disadvantage in building book value.
-92.85%
Cut dividends over 10 years while 0819.HK stands at 578.36%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 0819.HK stands at 522.43%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-22.12%
Firm’s AR is declining while 0819.HK shows 2.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
23.92%
Inventory growth well above 0819.HK's 41.30%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-8.19%
Negative asset growth while 0819.HK invests at 14.78%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.51%
Under 50% of 0819.HK's 11.51%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
38.08%
Debt growth far above 0819.HK's 32.99%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-67.10%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-20.20%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.